🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1b, multi-center, double-masked, randomized, placebo-contro...
Status
Completed
Location
Investigational Site
Start Date
2012-11
Trial ID
NCT01745887
Treatments Being Tested
This is a Phase III multi-center, double-masked, vehicle-controlled, random...
Status
Completed
Location
Multiple Locations
Start Date
2015-07
Trial ID
NCT02492321
Treatments Being Tested
This is a phase III double-masked, randomized, controlled study evaluating ...
Status
Completed
Location
Investigational Site
Start Date
2014-01
Trial ID
NCT01998802
Treatments Being Tested
Isunakinra - a potent Interleukin-1 receptor inhibitor - will be given to p...
Status
Completed
Location
Baylor Charles A. Simmons Cancer Center
Start Date
2020-09-01
Trial ID
NCT04121442
Treatments Being Tested
This is a randomized, double masked study designed to evaluate the safety o...
Status
Unknown
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT02405039
This is a Phase II Single Center, Randomized, Double-Masked, Vehicle-Contro...
Status
Completed
Location
Investigation Site
Start Date
2014-02
Trial ID
NCT02082899
Treatments Being Tested
This is a First-In-Human (FIH) study to assess the safety and tolerability ...
Status
Completed
Location
Celerion
Start Date
2012-11
Trial ID
NCT01748578
Treatments Being Tested